To identify clinicians' needs and their perspectives on the initial prototypes, I created an overall Affinity Diagram for the 3 rounds of interviews.
Focused on the Treatment Guidelines feature to understand the CDSS's impact in clinician workflow, and enhance its educational values for less experienced clinicians.
Focused on the "What-if" Scenario (What-if Exploration) feature to identify gaps and potentials in explainability of the AI.
"I would do this (use what-if exploration) pretty regularly. I'd probably play with it when I teach others about risk stratification. And this is a good teaching tool, even outside of clinical care"
Participant 8, Round 3
"If a patient is going the wrong direction, you want to see where I can intervene, that's going to make the biggest difference.”
Participant 7, Round 3
"Which one of the particular factors that makes somebody high risk? And what about those can we modify? And what effect will those modifications have down the road?” (questions the participant would ask himself)
Participant 11, Round 3
To identify key stakeholders and their respective needs, we created clinician workflow diagram based on the 3 rounds of interviews and conducted 2 additional semi-structured interviews.
Based on the insights from the Affinity Diagram and the clinician workflow, we decided to focus on:
To address the issues identified from previous interviews, and enhance the new PHORA tool's functionalities in communication and education, I redesigned the PHORA interface overall based on the interview insights and clinician feedback from weekly PHORA team meetings.
I mainly focused on iterating the What-if Exploration feature, which is the central feature for explaining the AI, and educating patients or non-specialists. I iterated on its layout and visualizations for easier interactivity and more efficient information display.
Developed the prototype with Katelyn Morrison and Shuyi Han. The current prototype is developed with Svelte, hosted with Firebase, and connected to the latest PHORA bayesian patient risk prediction model.